Skip to content
lifestyle.friendhood.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
BioXcel Therapeutics
BioXcel Therapeutics Announces Approximately $8.0 Million Registered Direct Offering
March 11, 2026
BioXcel Therapeutics Announces Approximately $8.0 Million Registered Direct Offering
March 11, 2026
BioXcel Therapeutics Announces Positive Phase 2 Topline Results from Columbia University-Led Study of BXCL501 for Treatment of Opioid Withdrawal
March 5, 2026
BioXcel Therapeutics Completes Market Opportunity Assessment and Advances Commercialization Plans for IGALMI® in the At-Home Setting
February 17, 2026
←
Previous Page
1
2